AI channel feed

Cash, chips and tal­ent: In­side Nvidi­a's plan to dom­i­nate biotech's AI rev­o­lu­tion

Last year
R&D
In Focus

Ex­clu­sive: Ex-Re­cur­sion team launch­es Leash Bio, chal­leng­ing AI field with its bet on need­ing more da­ta

Last year
Financing

ARPA-H calls on AI de­vel­op­ers to help tack­le cy­ber­at­tacks

Last year
FDA+
Health Tech

Ex­clu­sive: ‘If you could hal­lu­ci­nate a pro­tein’: Proflu­ent snags $35M for gen­er­a­tive AI mod­els

Last year
Financing
Startups

David Bak­er’s lab shows gen­er­a­tive AI can de­sign an­ti­bod­ies. But are they good enough to be­come drugs?

Last year
R&D

‘An AI foundry’: Nvidia’s Jensen Huang pitch­es biotech on easy AI, with fo­cus on soft­ware go­ing be­yond chips

Last year

No­vo Nordisk Foun­da­tion backs ef­fort to build su­per­com­put­er with Nvidia

Last year
R&D

FDA lays out cross-agency ef­forts on reg­u­lat­ing AI in med­ical prod­ucts

Last year
Pharma
FDA+

Ex­clu­sive: ‘Chat­G­PT for DNA’: Re­la­tion nabs $35M, with Nvidia back­ing, for os­teo­poro­sis work

Last year
Financing
Startups

David Bak­er's lab re­leas­es new pro­tein de­sign and study tools as AI race ac­cel­er­ates

Last year
R&D
Discovery

Health tech in­vestors out­line in­vest­ment pri­or­i­ties in AI

Last year
Health Tech

Biden ad­min­is­tra­tion in­vests $48M in AI/ML plat­form to iden­ti­fy rare dis­ease drugs

Last year
Pharma
FDA+

Owkin launch­es new start­up to ‘cap­ture laws of bi­ol­o­gy’ with $35M seed round

Last year
Financing
Startups

Cor­rec­tion: Iambic says new AI mod­el bests Al­phaFold as pro­tein mod­els rock­et ahead

Last year
R&D

FDA to mod­ern­ize drug sur­veil­lance in­ter­nal­ly with use of AI

Last year
FDA+

Schrödinger takes a step for­ward with Al­phaFold in drug R&D, as biotech hits a pipeline 'in­flec­tion'

Last year
R&D

Cre­ative AI gains steam among phar­ma mar­keters in­clud­ing Sanofi, No­var­tis, al­though con­cerns abound

Last year
Pharma
Marketing

#JPM24 quick hits: Vibe check; Maze’s next turn; AI at phar­ma com­pa­nies + more

Last year
Deals
Pharma

Ex­clu­sive: Al­pha­bet's Iso­mor­phic inks first phar­ma deals with Eli Lil­ly and No­var­tis for $83M up­front, $2.9B in mile­stones

Last year
Startups
Deals

For­mer ex­ecs from Pfiz­er obe­si­ty drug pro­gram have start­ed a new biotech with $52M from VC fund ATP

Last year
Financing
Startups

Ex­clu­sive: Aviv Regev talks three years of lead­ing Genen­tech’s re­search, the fu­ture of AI, and not mak­ing No­bel pre­dic­tions

Last year
People
R&D

Aviv Regev leads Genen­tech's next rev­o­lu­tion with AI

Last year
R&D
In Focus

Sanofi forms drug dis­cov­ery pact with French start­up Aqemia en route to ‘AI at scale’ am­bi­tion

Last year
Startups
Deals

UCSF sci­en­tists aim to un­rav­el autism with brain organoids and AI

Last year
R&D
First page Previous page 3456789 Next page Last page
A service from the Financial Times